The primary therapeutic role of Xue Fei (Loratadine) is to offer supportive symptomatic assistance across domains characterized by allergic responses, providing support that helps ease the overall symptom load. It is relevant in clinical settings marked by heightened patient distress caused by symptoms related to heightened physiological activity. It is commonly used to help with conditions involving episodic or fluctuating manifestations, specifically allergic rhinitis (seasonal hay fever and year-round perennial allergies) and chronic urticaria (hives).

“The medication is generally used in contexts where symptoms may escalate temporarily and short-term symptomatic assistance is needed.”

The medication is relevant for easing the acute and recurrent discomfort of upper respiratory and ocular symptoms, providing supportive relief when symptoms interfere with daily functioning. It is applied in addressing the disruptive symptom cluster of sneezing, runny nose, nasal itching, and watery, itchy eyes, contributing to easing day-to-day comfort during periods of heightened symptoms. It is also applied in addressing conditions presenting with significant symptomatic burden, such as persistent itching and the appearance of welts associated with allergic skin reactions.

Quick Fact: Relief for Allergic Discomfort
Condition Category	Conditions characterized by periods of heightened symptoms.
Key Benefit	Helps maintain a sense of stability when symptoms are more noticeable.
Relief Focus	Itching, sneezing, and watery eyes.
Use Context	Applied during phases when symptoms become more noticeable.

Regulatory References

1. NIH MedlinePlus overview of Loratadine uses

Who Can and Cannot Use Xue Fei?

Official regulatory documentation defines eligibility for Xue Fei (Loratadine) based on specific patient demographics and clinical status.

Absolute Contraindication: The medicine is strictly contraindicated for patients with a known hypersensitivity to the active substance, Loratadine, its active metabolite (desloratadine), or any of the product's excipients.

Age-Related Eligibility: Use is officially established for adults, adolescents, and children 2 years of age. Use in children under 2 years of age is not recommended by regulatory authorities due to insufficient safety and effectiveness data.

Conditional Use Status: Use requires special consideration in certain populations. Patients with severe hepatic impairment or severe renal impairment (Glomerular Filtration Rate < 30 mL/min) are deemed conditionally eligible, as official labels recommend a modified dosing regimen due to potential reduced clearance.

Physiological Status Restrictions: The medicine is not recommended for women who are pregnant or breastfeeding, as the active substance is known to pass into breast milk and clinical data are limited. Additionally, its use must be discontinued 48 hours prior to allergy skin testing to prevent interference with test results.

Xue Fei Interactions with other medicines and products

The interaction profile of Xue Fei (Loratadine) is characterized by documented pharmacokinetic changes (drug concentration) and pharmacodynamic effects (additive action).

Officially Documented Interactions

Interacting Product Category	Official Interaction Outcome
Specific CYP Inhibitors	Co-administration with Ketoconazole, Erythromycin, or Cimetidine substantially increases the plasma concentrations of Loratadine and its active metabolite due to enzyme inhibition [accessdata.fda.gov].
Food	Ingestion with food increases the systemic bioavailability (AUC) of Loratadine by approximately 40% to 48% [accessdata.fda.gov].
CNS Depressants and Alcohol	Risk of additive sedation or drowsiness due to a pharmacodynamic effect [reference.medscape.com].

Metabolic Basis and Population Notes

Loratadine is metabolized primarily by the CYP3A4 enzyme and secondarily by CYP2D6. Inhibition of these enzymes by concurrent medicines is the main basis for increased drug levels. No mandatory timing-separation rule is specified in the regulatory labels.

Patients with severe hepatic impairment (liver disease) or renal impairment (kidney failure, GFR < 30 mL/ min) are noted to have reduced clearance of the drug, leading to the potential for elevated concentrations and increased risk of accumulation-related effects [accessdata.fda.gov].

Selective H1-Receptor Blockade

Xue Fei functions as a selective antagonist (inverse agonist) at the peripheral Histamine H1 Receptor. This molecular action involves competitive binding to the receptor, thereby interfering with the signaling cascade that is normally initiated by endogenous histamine. This mechanism modulates the influence of the mediator on vascular and sensory systems.

Modulation of Peripheral Pathways

The drug's molecular action directly affects the microvasculature and peripheral sensory nerves. By blocking the H1-receptor on vessel walls, the drug modulates the signaling that would normally lead to cellular separation and vasodilation. This alteration limits the histamine-induced increase in vascular permeability. Simultaneously, this antagonism limits the activation of peripheral sensory nerve endings. The resulting physiological change is the attenuation of microvascular extravasation (fluid leakage), which influences the physiological component of local tissue fluid accumulation.

Mechanistic Non-Sedating Profile

The drug's structural properties, coupled with its high affinity for the P-glycoprotein efflux transporter, restrict its passage across the blood-brain barrier (BBB). This mechanism ensures the H1-receptor blockade is focused on the periphery, resulting in reduced influence on the Central Nervous System (CNS) histaminergic system and defining the drug's peripheral selectivity.

How to Use Xue Fei (Loratadine) — Administration Guidelines

The general principles for using Xue Fei (Loratadine) are based on a standardized, once-daily regimen for oral administration.

Standard Dosing and Frequency

Age Group	Standard Once-Daily Dose
Adults and Children 12 years and older	10 mg once daily (e.g., one tablet)
Children 6 to 12 years	10 mg once daily (for body weight >30 kg)
Children 2 to 5 years	5 mg once daily (often using liquid or chewable forms)

Administration Requirements

Administration is oral and may be performed without regard to mealtime. The available dosage forms include conventional tablets, oral solutions, and orally disintegrating tablets (ODT). Users of the oral solution must utilize a calibrated measuring device to ensure accurate dose delivery, as household spoons are not recommended for precise measurement.

Population-Specific Adjustments

Dose modifications are utilized for individuals with severe organ impairment. The dose is typically adjusted to 10 mg every other day for adults and children weighing over 30 kg who have severe hepatic impairment (liver disease). A similar every-other-day schedule may apply to patients with severe renal impairment (kidney disease), though specific recommendations may vary.

Procedural Note

If a dose is forgotten, the instruction is to take the missed dose as soon as it is remembered; however, if it is nearly time for the next scheduled dose, the missed dose should be skipped to prevent taking a double dose. Furthermore, administration should be discontinued at least 48 hours before any planned allergy skin tests to prevent interference with the diagnostic results.

Research Evidence / Overview of Studies

Clinical research has investigated the compound Xue Fei (often identified in research by associated formulations such as Bu-Fei-Huo-Xue and Xuanfei Baidu). The available evidence largely focuses on its use in respiratory and inflammatory conditions, primarily through multi-center, randomized, controlled trials and systematic reviews.

---

Research Focus Areas

Studies have investigated the effects of the compound on the body, with research protocols examining markers related to circulation and inflammatory response. This compound is the subject of ongoing research to better describe its biochemical activity.

Clinical Investigation

Clinical research has investigated the application of this compound across various conditions.

I. Measurement of Chronic Symptom Markers

Initial studies and Phase I/II trials have examined the use of the treatment in relation to chronic symptom markers, such as fatigue and discomfort. Some studies have evaluated measured changes in general malaise in specific patient populations, including those recovering from severe respiratory illness.

II. Adjunctive Therapy Research

Research has evaluated whether the use of the combination therapy is associated with different patient outcomes when used alongside standard treatments. Preliminary observational data suggests that researchers are exploring its use in this context; however, evidence remains limited, and results were varied. Further randomized controlled trials are needed to clarify any potential association.

---

Tolerability Findings

Studies have monitored the effects of its use over extended periods, primarily focusing on general adverse events reported by study participants. Research has examined the short-term profile, reporting specific adverse events observed in study participants, including mild gastrointestinal distress, temporary fatigue, skin pruritus (itching), and erythra (redness).

Research protocols have often excluded individuals with pre-existing severe cardiovascular conditions or kidney impairment from participation. Ongoing monitoring continues to focus on hepatic and renal function markers in long-term observational cohorts. The available data primarily describe the adverse event profiles observed in research settings.

Common questions about Xue Fei (FAQ)

---

Q: Is Xue Fei a common prescription drug?

Official information indicates that Xue Fei is widely available as an over-the-counter (OTC) medicine in many regions. While it may have originally been prescription-only, its current status generally reflects its wide availability.

Q: What are the most frequently reported side effects of Xue Fei?

Studies and official information indicate that the most commonly reported side effects observed in clinical trials for both children and adults included headache, nervousness, and fatigue. These reports are based on adverse events observed during formal research.

Q: Is weight gain or fatigue associated with taking Xue Fei?

Yes, fatigue is listed as a common adverse reaction reported in clinical trials. Weight increase is also noted in official documentation as a reported adverse experience, classified by regulatory sources as very rare or frequency unknown.

Q: Is it normal to feel [vague symptom, e.g., slightly dizzy] after starting Xue Fei?

Official product information lists dizziness as a very rare adverse experience. If any new or unusual symptoms are experienced, official regulatory guidance indicates that these should be discussed with a healthcare professional.

Q: What common over-the-counter medicines or supplements interact with Xue Fei?

According to the official product information, certain medicines that inhibit the liver enzymes CYP3A4 and CYP2D6 may lead to increased concentrations of the drug in the body. Official documents advise that caution is warranted when taking any product that may affect liver enzyme activity.

Q: Are there any foods or drinks that should be avoided when taking Xue Fei?

The medicine can be taken without regard to mealtime; however, consuming it with food can lead to increased absorption of the drug. Official labels warn that additive sedation or drowsiness is possible if the medicine is combined with alcohol or other Central Nervous System (CNS) depressants.

Q: How long does it take for Xue Fei to start working?

Studies and official information indicate that the antihistaminic effect of Xue Fei typically begins within one to three hours after administration. The maximum effect on allergic symptoms is usually reached between eight and twelve hours after the dose.

Q: What is the total duration of time Xue Fei stays in the body?

Pharmacokinetic data in regulatory documents indicate that the elimination of the drug takes time. The mean elimination half-life for the active ingredient is approximately 8.4 hours (range 3 to 20 hours), and the half-life of its major active metabolite is approximately 28 hours (range 8.8 to 92 hours).

Q: What should I expect when I first begin treatment with Xue Fei?

When beginning treatment, official information suggests the drug provides 24-hour relief from allergy symptoms. The drug is designed to be non-sedating. However, official sources note that rare side effects like headache, nervousness, or temporary fatigue may occur. Caution is advised regarding the use of alcohol due to the potential for increased drowsiness.

Q: Is Xue Fei appropriate for older adults?

The way the drug is processed in the body for healthy older adults is generally comparable to that of younger adults. However, for older patients who have severe liver or kidney impairment, official labels note that dosage modification may be necessary for these individuals.

Q: Is Xue Fei considered a controlled substance?

Official government drug schedules and classifications state that the active ingredient in Xue Fei, Loratadine, is not classified as a controlled substance in the United States.

Q: Is it necessary to take Xue Fei at the exact same time every day?

Xue Fei is designed as a once-daily medicine to provide 24-hour symptom relief. Taking the medicine at a consistent time each day supports the reliable maintenance of steady drug levels in the body.

Q: Can Xue Fei affect my ability to drive or operate machinery?

Official regulatory documents indicate that in clinical trials, no impairment occurred in most patients. However, because very rarely some people may experience drowsiness, official labels advise that people should be aware of their individual reaction before operating machinery or driving.

Q: Is hair loss a potential side effect listed in official documents?

Yes, official regulatory documentation lists alopecia (hair loss) as a very rare adverse experience. This is based on reports received in post-marketing surveillance.

Q: Can Xue Fei be crushed or split, according to the manufacturer?

Official documents note that standard tablets are designed for oral administration. Specific dosage forms, like chewable tablets, are directed to be chewed, but standard tablets are generally not intended to be divided, crushed, or chewed unless specified by the product manufacturer.

Q: Are there any warnings about using Xue Fei with other psychiatric medications?

Official interaction labels include warnings about using the drug with Central Nervous System (CNS) depressants. This general category includes certain psychiatric medications, such as sedatives or some antidepressants, due to the potential for additive drowsiness or sedation.

Q: If I am allergic to certain ingredients, how do I check if Xue Fei is safe?

The drug is contraindicated in cases of known hypersensitivity to the active substance, its active metabolite, or any of the inactive ingredients (excipients). These excipients are listed in the full prescribing information provided by the regulatory authority.

Q: Are there any restrictions on using Xue Fei with herbal supplements?

While specific herbal supplements are not generally listed, the drug is metabolized by specific liver enzymes (CYP3A4 and CYP2D6). Official sources indicate that caution is warranted when considering any product that may inhibit or affect these enzymes.

Q: What are the conditions under which Xue Fei is not recommended?

Official regulatory documents state that the drug is strictly contraindicated if a patient is allergic to its components. Additionally, it is not recommended for use in children under two years of age, or for women who are pregnant or breastfeeding.

Q: Does Xue Fei require any special monitoring (e.g., blood tests) during treatment?

Special caution is required for patients with severe liver impairment or severe renal (kidney) impairment. The necessity of special monitoring, such as blood tests, is determined on an individual basis.

Q: Is it common to experience sleep pattern changes while on Xue Fei?

Official adverse reaction lists include insomnia (difficulty sleeping) as a very rare adverse experience. However, the product is generally known for its non-sedating profile.

Q: How is the mechanism of action of Xue Fei simplified for patients?

Xue Fei is a long-acting selective antihistamine. This means it works by blocking the effects of a substance naturally released by the body called histamine, which is responsible for triggering common allergic symptoms.

Q: Does Xue Fei have a black box warning from the FDA?

Official review of the drug's safety information confirms that the active ingredient in Xue Fei, Loratadine, does not carry a Boxed Warning (also known as a black box warning) from the U.S. Food and Drug Administration (FDA).

Q: What is the risk of having a serious allergic reaction to Xue Fei?

Official documentation lists serious hypersensitivity reactions (including swelling of the face/throat and anaphylaxis) as a very rare adverse experience. Official guidance indicates that use should be stopped and immediate medical help sought if any signs of a severe allergic reaction occur.

The storage and disposal of Xue Fei (Loratadine) must strictly follow the conditions defined in official regulatory labeling to ensure product stability and safety.

---

Mandatory Storage Conditions

The product must be stored at controlled room temperature, maintaining a required range typically between 20°C and 25°C (68°F and 77°F). It is essential to store the medicine protected from excessive moisture and a regulatory instruction requires that the product must not be frozen. Tablets and solution should remain in the original container.

---

Disposal and Safety

All medications must be stored out of the reach and sight of children. For disposal, unused or expired product must not be thrown into wastewater or household trash. Instead, dispose of the medicine according to local requirements for pharmaceutical waste, as directed by official documents.